Use of physiological doses of human growth hormone in haematological patients receiving intensive chemotherapy promotes haematopoietic recovery: a double-blind randomized, placebo-controlled study.
第一作者:
B,Sirohi
第一单位:
Haemato-Oncology Unit, Royal Marsden Hospital and Institute of Cancer Research, Sutton, Surrey, UK.
作者:
医学主题词
青少年(Adolescent);成年人(Adult);老年人(Aged);交叉研究(Cross-Over Studies);双盲法(Double-Blind Method);女(雌)性(Female);血液病(Hematologic Diseases);血细胞生成(Hematopoiesis);人生长激素(Human Growth Hormone);人类(Humans);白血病(Leukemia);白细胞计数(Leukocyte Count);男(雄)性(Male);中年人(Middle Aged);多发性骨髓瘤(Multiple Myeloma);肿瘤分期(Neoplasm Staging);安慰剂(Placebos);血小板计数(Platelet Count);复发(Recurrence);全身照射(Whole-Body Irradiation)
DOI
10.1038/sj.bmt.1705545
PMID
17143302
发布时间
2007-01-10
- 浏览124
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



